This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Illumina’s challenge of EU’s latest Grail hold-separate measures: EU court publishes summary

( February 20, 2023, 09:43 GMT | Official Statement) -- MLex Summary: Illumina’s appeal of the European Commission’s recent decision to renew interim measures related to its Grail acquisition has been summarized by the EU General Court in the official journal. Illumina says the conditions for the adoption of interim measures haven't been met, and that the decision is disproportionate. The commission committed errors of facts and assessment and failed to provide sufficient reasons, the notice reads.Official Journal notice follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login